BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Tsao SY. Potential of mRNA vaccines to become versatile cancer vaccines . World J Clin Oncol 2022; 13(8): 663-674 [PMID: 36160466 DOI: 10.5306/wjco.v13.i8.663]
URL: https://www.wjgnet.com/2218-4333/full/v13/i8/663.htm
Number Citing Articles
1
Shihan Peng, Fengping Hou, Xinyu Yang, Wan Wang, Xiaomeng Li, Yue Tang, Yueru Chen, Chu Yang, Xiongxiong Li. Therapeutic mRNA vaccines targeting human papillomavirus type 16 E7 protein demonstrate significant antitumor efficacy in murine models of HPV-associated tumorsInternational Journal of Pharmaceutics 2025; 680: 125785 doi: 10.1016/j.ijpharm.2025.125785
2
Zuchen Song, Lan Jin, Lina Jiao, Ruihong Yu, Huina Liu, Shun Zhang, Yaoren Hu, Yuechao Sun, Entao Li, Guofang Zhao, Zhenguang Liu, Ting Cai. ALC-0315 Lipid-Based mRNA LNP Induces Stronger Cellular Immune Responses PostvaccinationMolecular Pharmaceutics 2025; 22(2): 859 doi: 10.1021/acs.molpharmaceut.4c00995
3
Falak Goyal, Anandini Chattopadhyay, Umashanker Navik, Aklank Jain, P. Hemachandra Reddy, Gurjit Kaur Bhatti, Jasvinder Singh Bhatti. Advancing Cancer Immunotherapy: The Potential of mRNA Vaccines As a Promising Therapeutic ApproachAdvanced Therapeutics 2024; 7(2) doi: 10.1002/adtp.202300255